• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [25 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2024 Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: urethral discharge - diagnostic measures and pharmacological treatment]
2024 Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: unusual vaginal discharge - diagnostic measures and pharmacological treatment]
2024 Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: syndromic approach - pharmacological treatment]
2024 Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: confirmed chlamydia trachomatis or neisseria gonorrhoeae infection]
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis by NAAT]
2020 Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use guide: pharmacological treatment of sexually transmitted and blood-borne infections ─ infections caused by chlamydia trachomatis and neisseria gonorrhoeae]
2019 Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated in June 2019: urethral discharge]
2018 Canadian Agency for Drugs and Technologies in Health (CADTH) Screening for chlamydia trachomatis and neisseria gonorrhoeae during pregnancy: a health technology assessment
2016 NIHR Health Technology Assessment programme The natural history of Chlamydia trachomatis infection in women: a multi parameter evidence synthesis
2015 NIHR Health Technology Assessment programme The relative clinical and cost-effectiveness of three contrasting approaches to partner notification for curable sexually transmitted infections (STIs): a cluster randomised trial in primary care
2012 Malaysian Health Technology Assessment (MaHTAS) Point-Of-Care test for Chlamydia
2010 The Swedish Council on Health Technology Assessment (SBU) [Urine specimens in diagnosing chlamydia in women]
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Urine based testing for gonorrhea and chlamydia: a review of diagnostic accuracy, cost-effectiveness, and compliance
2007 NIHR Health Technology Assessment programme A study to evaluate the most cost-effective way to screen for Chlamydia trachomatis genital tract infection and reduce its prevalence and associated burden of disease - primary research
2007 NIHR Health Technology Assessment programme Epidemiological, social, diagnostic, and economic evaluation of population screening for genital chlamydial infection
2007 Adelaide Health Technology Assessment (AHTA) Opportunistic screening of asymptomatic individuals for Chlamydia
2007 Basque Office for Health Technology Assessment (OSTEBA) [Sexually transmitted diseases. Situation in the Basque Autonomous Community. Effectiveness of preventive measures]
2006 Adelaide Health Technology Assessment (AHTA) Rapid point-of-care for the detection of Chlamydia in individuals at risk of trachoma
2005 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Screening on urogenital chlamydia trachomatis
2004 Health Council of the Netherlands Gezondheidsraad (GR) [Screening for chlamydia]
2003 L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Assessment of screening for Chlamydia trachomatis infection of the lower genitourinary tract in France
2003 L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Place of molecular biology methods in detecting Chlamydia trachomatis infection of the lower genitourinary tract
2002 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Chlamydia screening with home testing - a health technology assessment]
2002 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Screening for chlamydia with hometest]
2001 Agency for Healthcare Research and Quality (AHRQ) Screening for chlamydial infection